Postmarketing drug surveillance: are our priorities right?
Fries
J F
JF
D000893:Anti-Inflammatory Agents / Q000009:adverse effects; D005069:Evaluation Studies as Topic; D005767:Gastrointestinal Diseases / Q000139:chemically induced / Q000401:mortality; D006801:Humans; D011358:Product Surveillance, Postmarketing
D000893:Anti-Inflammatory Agents